Bristol Myers Squibb (BMY)

Cost of Revenue

$3.73B

Quarterly · Period ending: · USD

BMY logo

BMY Cost of Revenue

Latest reported$3.73B
BMY Quarterly Cost of Revenue ($0.00 → $3.73B)
High-resolution chart · PNG

BMY cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bristol Myers Squibb Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
3,726,000,000
3,421,000,000
4,097,000,000
3,435,000,000
3,372,000,000
3,033,000,000
4,812,000,000
2,957,000,000
3,267,000,000
2,932,000,000
2,745,000,000
2,506,000,000
2,876,000,000
2,566,000,000
2,593,000,000
2,353,000,000
2,720,000,000
2,471,000,000
2,356,000,000
2,291,000,000
2,452,000,000
2,841,000,000
2,910,000,000
2,502,000,000
2,699,000,000
3,662,000,000
2,432,000,000
1,790,000,000
1,972,000,000
1,824,000,000
1,690,000,000
1,648,000,000
1,625,000,000
1,584,000,000
1,673,000,000
1,579,000,000
1,569,000,000
1,265,000,000
1,383,000,000
1,305,000,000
1,206,000,000
1,052,000,000
952,000,000
1,097,000,000
1,013,000,000
847,000,000
966,000,000
1,007,000,000
991,000,000
968,000,000
1,273,000,000
1,175,000,000
1,108,000,000
1,063,000,000
1,075,000,000
987,000,000
1,245,000,000
1,303,000,000
1,367,000,000
1,407,000,000
1,481,000,000
1,343,000,000
1,414,000,000
1,280,000,000
1,277,000,000
1,306,000,000
704,000,000
1,317,000,000
1,225,000,000
1,165,000,000
1,522,000,000
1,634,000,000
1,670,000,000
1,570,000,000
1,655,000,000
1,478,000,000
1,408,000,000
1,340,000,000
1,447,000,000
1,465,000,000
1,568,000,000
1,476,000,000
1,595,000,000
1,483,000,000
1,483,000,000
1,367,000,000
-105,000,000
1,467,000,000
1,500,000,000
1,357,000,000
2,203,000,000
1,929,000,000
1,852,000,000
1,709,000,000
1,766,000,000
1,654,000,000
1,466,000,000
1,502,000,000
1,614,000,000
1,317,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.